Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic and therapeutic significance of microscopic tumor focus in combined hepatocellular-cholangiocarcinoma: a multicenter pathological study.

Journal of gastrointestinal oncology·2026
Same author

Tumor component proportion determines the prognosis of patients with combined hepatocellular-cholangiocarcinoma.

Hepatobiliary & pancreatic diseases international : HBPD INT·2026
Same author

A Grading System of Intratumoral Tertiary Lymphoid Structure for Combined Hepatocellular-Cholangiocarcinoma: A Multicenter Pathological Study.

Journal of hepatocellular carcinoma·2026
Same author

Deciphering the significance of tumor necrosis and developing a grading system in combined hepatocellular-cholangiocarcinoma: A multicenter pathological study.

Pathology, research and practice·2025
Same author

Immunohistochemistry in intrahepatic cholangiocarcinoma: histological subtyping and drug selection.

Frontiers in oncology·2025
Same author

Perineural invasion as a prognostic determinant in combined hepatocellular-cholangiocarcinoma: a multicenter pathological study.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2025

Related Experiment Video

Updated: Apr 6, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K

Small hepatocellular carcinoma: current and future approaches.

Wen-Ming Cong1, Meng-Chao Wu2

  • 1Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Changhai Road 225, Shanghai, 200438, China. wmcong@gmail.com.

Hepatology International
|July 24, 2015
PubMed
Summary

Defining small hepatocellular carcinoma (SHCC) size is crucial for prognosis. Current criteria lack global consensus, necessitating a review of pathobiological features and clinical significance for better patient outcomes.

Keywords:
Early hepatocellular carcinomaGuidelinesPathobiological featuresSmall hepatocellular carcinomaSurgical outcome

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.7K
Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

2.9K

Related Experiment Videos

Last Updated: Apr 6, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.7K
Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

2.9K

Area of Science:

  • Hepatology
  • Oncology
  • Pathobiology

Background:

  • Small hepatocellular carcinoma (SHCC) is a key prognostic factor in liver cancer.
  • Early detection and accurate staging are vital for predicting patient outcomes.
  • Lack of a standardized size criterion for SHCC hinders consistent clinical management.

Purpose of the Study:

  • To review the historical context of SHCC research.
  • To analyze the limitations of existing size criteria for SHCC.
  • To discuss the pathobiological characteristics and clinical significance of SHCC.

Main Methods:

  • Literature review of SHCC studies.
  • Analysis of existing size cutoff values (e.g., 5 cm, 3 cm, 2 cm).
  • Discussion of pathobiological features and clinical implications.

Main Results:

  • Over three decades of SHCC research highlight its prognostic importance.
  • Numerous, varied size criteria (e.g., 5, 3, 2 cm) exist globally without consensus.
  • Understanding pathobiological features is essential for defining SHCC aggressiveness.

Conclusions:

  • A unified size criterion for SHCC is currently lacking.
  • Further investigation into pathobiological characteristics is needed to refine SHCC classification.
  • Standardizing SHCC definition will improve prognostic accuracy and clinical decision-making.